UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.20549



FORM 10-Q



(Mark One)

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the quarterly period ended:   December 31, 2017September 30, 2021


☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from ____________________ to ____________________.

Commission file number: 000-50053

amerityre20210930_10qimg001.jpg

000-50053

AMERITYRE CORPORATION

(Exact name of small business issuer as specified in its charter)


NEVADA

87-0535207

(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization)

Identification No.)


1501 INDUSTRIAL ROAD, BOULDER CITY, NEVADAIndustrial Rd., Boulder City, NV

89005

(Address of principal executive offices)

(Zip Code)


(702) 293-1930

(Issuer’s telephone number)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes    No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes     No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company.  See definitionthe definitions of “large accelerated filer,” accelerated“accelerated filer” and “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:Act.


Large accelerated filer  ☐

Accelerated filer  ☐ 

Non-accelerated filer  ☒

Smaller reporting company ☒

Emerging Growth Companies ☐

Large accelerated filer        Accelerated filer        Non-accelerated filer        Smaller reporting company ☒        Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes   No 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

N/A

N/A

N/A

The number of shares outstanding of Registrant’s Common Stock as of February 14, 2018: 43,976,346November 15, 2021: 73,047,868


TABLE OF CONTENTS


  

Page

PART I

Item 1.

Financial Statements

3

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operation

11

10

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

19

16

Item 4.

19

16

PART II

Item 1.

Legal Proceedings

20

17

Item 1A.

Risk Factors

20

17

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

20

17

Item 3.

Defaults Upon Senior Securities

20

17

Item 4.

Mine Safety Disclosures

Not Applicable

20

17

Item 5.

Other Information

20

17

Item 6.

Exhibits

20

17

   

SIGNATURES

21

18

 

 

Table of Contents

PART I - FINANCIAL INFORMATION


ITEM 1.FINANCIAL STATEMENTS

AMERITYRE CORPORATION

Balance Sheets

 
December 31,
2017
  
June 30,
2017
 
 (Unaudited)     

September 30, 2021

  

June 30, 2021

 
ASSETS       

(Unaudited)

     
        
CURRENT ASSETS              
Cash $130,456  $340,256  $476,220  $516,192 
Accounts receivable  492,215   284,004   530,940   728,315 
Inventory - net  548,973   576,191 

Current inventory - net

  739,188   659,333 
Prepaid and other current assets  146,306   112,368   144,412   94,483 
Total Current Assets  1,317,950   1,312,819   1,890,760   1,998,323 
                

RIGHT TO USE LEASE ASSETS, OPERATING, NET

  506,473   544,070 
        
PROPERTY AND EQUIPMENT                
Leasehold improvements  195,808   196,223 
Molds and models  583,611   577,549   583,611   583,611 
Equipment  2,982,218   2,982,218   3,077,255   2,910,018 
Furniture and fixtures  59,057   74,921   73,423   73,423 

Software

  233,528   233,528 
Construction in progress  -   17,351   14,006   - 
Software  339,009   339,009 
Less - accumulated depreciation  (3,930,413)  (3,914,142)
Total Property and Equipment  229,290   273,129 

Less – accumulated depreciation

  (3,705,284

)

  (3,690,515

)

Property and Equipment - net

  276,539   110,065 
                
OTHER ASSETS                
Patents and trademarks - net  144,036   155,952 

Patents and trademarks – net

  71,043   75,977 
Non-current inventory  202,648   228,403   164,171   163,289 
Deposits  11,000   11,000   11,000   11,000 
Total Other Assets  357,684   395,355   246,214   250,266 
TOTAL ASSETS $1,904,924  $1,981,303  $2,919,986  $2,902,724 
                
LIABILITIES AND STOCKHOLDERS’ EQUITY                
        
CURRENT LIABILITIES                
Accounts payable and accrued expenses $506,641  $468,489  $706,866  $767,193 
Current portion of long-term debt  19,872   19,382   2,000   2,000 
Current portion of lease liability  4,755   6,967   148,050   147,600 
Deferred revenue  -   -   42,125   25,892 
Total Current Liabilities  531,268   494,838   899,041   942,685 
                
Long-term debt  115,133   124,482   61,326   61,326 
Long-term lease liability  -   1,426   263,250   300,600 
Total Long-Term Liabilities  115,133   125,908 
TOTAL LIABILITIES  646,401   620,746   1,223,617   1,304,611 
                

COMMITMENTS AND CONTINGENCIES

        
        
STOCKHOLDERS’ EQUITY                
Preferred stock: 5,000,000 shares authorized of $0.001 par value, 2,000,000 shares issued and outstanding, respectively  2,000   2,000 
Common Stock: 75,000,000 shares authorized of $0.001 par value, 43,312,107 and 43,312,107 shares issued and outstanding, respectively  43,312   43,312 

Common stock: 100,000,000 shares authorized of $0.001 par value, 73,047,868 and 73,047,868 shares issued and outstanding, respectively

  73,048   73,048 
Additional paid-in capital  62,616,457   62,615,728   62,805,404   62,805,404 
Stock payable  13,462   -   33,156   - 
Accumulated deficit  (61,416,708)  (61,300,483)  (61,215,239

)

  (61,280,339

)

Total Stockholders’ Equity  1,258,523   1,360,557   1,696,369   1,598,113 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $1,904,924  $1,981,303  $2,919,986  $2,902,724 

The accompanying notes are an integral part of these financial statements.


AMERITYRE CORPORATION

Statements of Operations

(Unaudited)

(Unaudited)

  
For the Three Months Ended
December 31,
  
For the Six Months Ended
December 31,
 
  2017  2016  2017  2016 
             
NET SALES $866,944  $879,607  $1,792,660  $1,715,760 
                 
COST OF GOODS SOLD  592,335   612,336   1,244,152   1,167,788 
                 
GROSS PROFIT  274,609   267,271   548,508   547,972 
                 
EXPENSES                
Research and development  53,002   56,185   111,143   109,044 
Sales and marketing  49,583   58,961   115,318   126,191 
General and administrative  173,328   147,477   368,279   339,783 
                 
Total Expenses  275,913   262,623   594,740   575,018 
                 
(LOSS) INCOME FROM OPERATIONS  (1,304)  4,648   (46,232)  (27,046)
                 
OTHER (EXPENSE)/INCOME                
Interest expense  (1,331)  (1,879)  (2,814)  (5,064)
Interest income  66   47   174   100 
Loss on asset abandonment  -   -   (17,352)  - 
Total Other (Expense)/Income  (1,265)  (1,832)  (19,992)  (4,964)
                 
NET (LOSS) INCOME  (2,569)  2,816   (66,224)  (32,010)
                 
Preferred Stock Dividend  (25,000)  (25,000)  (50,000)  (50,000)
                 
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS $(27,569) $(22,184) $(116,224) $(82,010)
                 
BASIC AND DILUTED LOSS PER SHARE $(0.00) $(0.00) $(0.00) $(0.00)
                 
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING  43,312,107   42,325,287   43,312,107   42,313,874 
  

For the Three Months Ended

September 30,

 
  

2021

  

2020

 
         

NET SALES

 

$

1,395,614

  

$

1,051,286

 
         

COST OF REVENUES

  

1,010,842

   

707,566

 
         

GROSS PROFIT

  

384,772

   

343,720

 
         

EXPENSES

        

Research and development

  

21,567

   

20,471

 

Sales and marketing

  

68,373

   

59,800

 

General and administrative

  

232,848

   

210,486

 
         

Total Expenses

  

322,788

   

290,757

 
         

INCOME FROM OPERATIONS

  

61,984

   

52,963

 
         

OTHER INCOME (EXPENSE)

        

Interest income

  

366

   

418

 

Loss on asset disposal

  

-

   

(2,853

)

Other income

  

2,750

   

3,255

 
         

Total Other Income, net

  

3,116

   

820

 
         

NET INCOME

 

$

65,100

  

$

53,783

 
         

BASIC AND DILUTED INCOME PER SHARE

 

$

0.00

  

$

0.00

 
         

WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING

  

73,047,868

   

70,172,868

 

The accompanying notes are an integral part of these financial statements.


AMERITYRE CORPORATION

Statements of Cash FlowsStockholders Equity

(Unaudited)

(Unaudited)

  
For the Six Months Ended
December 31,
 
  2017  2016 
CASH FLOWS FROM OPERATING ACTIVITIES      
Net loss $(66,224) $(32,010)
Adjustments to reconcile net loss to net cash provided (used) by operating activities:        
Depreciation and amortization expense  44,467   52,782 
Stock based compensation  14,191   15,223 
Loss on asset abandonment  17,352   - 
Changes in operating assets and liabilities:        
Accounts receivable  (208,211)  49,405 
Inventory and inventory reserve  52,973   37,348 
Prepaid and other current assets  (33,938)  (62,033)
Accounts payable and accrued expenses  (11,851)  (9,218)
Net Cash Provided (Used) by Operating Activities  (191,241)  51,497 
CASH FLOWS FROM INVESTING ACTIVITIES        
Purchase of property and equipment  (6,062)  (11,424)
Net Cash Used by Investing Activities  (6,062)  (11,424)
CASH FLOWS FROM FINANCING ACTIVITIES        
Payments on lease liability  (3,638)  (2,965)
Payments on notes payable  (8,859)  (5,609)
Net Cash (Used) by Financing Activities  (12,497)  (8,574)
NET INCREASE (DECREASE) IN CASH  (209,800)  31,499 
CASH AT BEGINNING OF PERIOD  340,256   267,302 
CASH AT END OF PERIOD $130,456  $298,801 
  

Common Stock

  

Additional

Paid in

  

Stock

  

Accumulated

     
  

Shares

  

Amount

  

Capital

  

Payable

  

Deficit

  

Total

 

Balance, June 30, 2020

  70,172,868  $70,173  $62,719,473  $-  $(61,538,675

)

 $1,250,971 

Stock option based compensation expense – options

  -   -   -   12,323   -   12,323 

Net income for the quarter

  -   -   -   -   53,783   53,783 

Balance, September 30, 2020

  70,172,868   70,173   62,719,473   12,323   (61,484,892

)

  1,317,077 

Stock option based compensation expense – options

  -   -   -   (12,323

)

  -   (12,323)

Stock based compensation expense for employee and Board of Director service

  1,250,000   1,250   22,560   -   -   23,810 

Net loss for the quarter

  -   -   -   -   176,852   176,852 

Balance, December 31, 2020

  71,422,868   71,423   62,742,033   -   (61,308,040

)

  1,505,416 

Stock option based compensation expense – options

  -   -   -   31,590   -   31,590 

Net income for the quarter

  -   -   -   -   80,651   80,651 

Balance, March 31, 2021

  71,422,868   71,423   62,742,033   31,590   (61,227,389

)

  1,617,657 

Stock option based compensation expense – options

  -   -   -   33,406   -   33,406 

Stock based compensation expense for employee and Board of Director service

  1,625,000   1,625   63,371   (64,996

)

  -   - 

Net loss for the quarter

  -   -   -   -   (52,950

)

  (52,950)

Balance, June 30, 2021

  73,047,868   73,048   62,805,404   -   (61,280,339

)

  1,598,113 

Stock based compensation expense for employee and Board of Director service

  -   -   -   33,156   -   33,156 

Net income for the quarter

  -   -   -   -   65,100   65,100 

Balance, September 30, 2021

  73,047,868  $73,048  $62,805,404  $33,156  $(61,215,239

)

 $1,696,369 
SUPPLEMENTAL SCHEDULE OF CASH FLOW ACTIVITIES      
       
Interest paid $2,815  $5,064 
Income taxes paid $-  $- 
         
NON-CASH INVESTING AND FINANCING ACTIVITIES        
         
Write off of previously reserved forklift tires $-  $81,224 
Purchase of fixed assets through debt $-  $95,625 
Accrued preferred stock dividends $50,000  $50,000 
Issuance of stock for stock payable $-  $4,500 
Write off fully depreciated fixed assets no longer in use $16,280  $- 


The accompanying notes are an integral part of these financial statements.


AMERITYRE CORPORATION

Statements of Cash Flows

(Unaudited)

  

For the Three Months Ended

September 30,

 
  

2021

  

2020

 

CASH FLOWS FROM OPERATING ACTIVITIES

        

Net income

 $65,100  $53,783 

Adjustments to reconcile net income to net cash provided (used) by operating activities:

        

Depreciation and amortization expense

  60,050   55,062 

Stock based compensation

  33,156   12,323 

Loss on asset disposal

  -   2,853 

Changes in operating assets and liabilities:

        

Accounts receivable

  197,375   (30,611

)

Prepaid and other current assets

  (86,256

)

  (39,668

)

Inventory and any change in inventory reserve

  (80,737

)

  (13,144

)

Accounts payable and accrued expenses

  (74,332

)

  (57,116

)

Deferred revenue

  16,233   5,475 

Lease liability payable, operating lease

  (36,901

)

  (36,450

)

Net Cash Provided (Used) by Operating Activities

  93,688   (47,493

)

         

CASH FLOWS FROM INVESTING ACTIVITIES

        

Purchase of property and equipment

  (130,910

)

  - 

Cash paid for leasehold improvements of an operating lease

  (2,750

)

  - 

Net Cash Used by Investing Activities

  (133,660

)

  - 
         

CASH FLOWS FROM FINANCING ACTIVITIES

        

Payments on notes payable

  -   (263

)

Net Cash Used by Financing Activities

  -   (263

)

         

NET DECREASE IN CASH

  (39,972

)

  (47,756

)

CASH AT BEGINNING OF PERIOD

  516,192   666,756 

CASH AT END OF PERIOD

 $476,220  $619,000 

NON-CASH FINANCING ACTIVITIES

        
         

Interest paid

 $-  $- 

Income taxes paid

  -   - 
         

SUPPLEMENTAL SCHEDULE OF CASH FLOW ACTIVITIES

        
         

Use of store inventory, capitalized as fixed asset

 $-  $6,600 

Prepaid asset applied to capitalized equipment

 $36,327  $- 

Costs accrued for construction in progress

 $14,006  $- 

The accompanying notes are an integral part of these financial statements.

AMERITYRE CORPORATION

Notes to the Unaudited Condensed Financial Statements

September 30, 2021

December 31, 2017


NOTE 1 - – BASIS OF FINANCIAL STATEMENT PRESENTATION

The accompanying unaudited condensed financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission.Commission (“SEC”).  Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with such rules and regulations.  The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements.  We believe the disclosures and information presented are adequate to make the information not misleading.  These interim condensed financial statements should be read in conjunction with our most recent audited financial statements and notes thereto included in our June 30, 20172021 Annual Report on Form 10-K.  Operating results for the quarter ended December 31, 2017September 30, 2021 are not necessarily indicative of the results that may be expected for the current fiscal year ending June 30, 2018.2022.

NOTE 2 - – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


Significant accounting policies disclosed thereinherein have not changed since our audited financial statements and notes thereto included in our June 30, 20172021 Annual Report on Form 10-K, except as noted below.


Revenue Recognition


The majority of our revenue is derived from short-term sales contracts. We account for revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers”, which we adopted on July 1, 2017, using the modified retrospective method..


Revenue for our products is recognized at the time in which our performance obligation is satisfied which we have defined as “control” of the product by the customer. “Control” is defined as a customer having “rights/obligations of physical control over the product or has the rights and intention to control the product.” Based on the terms of our contracts, a customer’s “control” is based on analysis of the following; (i) when a customer arranges their own shipping, and once the product has left our dock, Amerityre Corporation (“Amerityre” or the “Company”) recognizes revenue for the product.  In effect by arranging their own shipping the customer is “taking control” of the product when it leaves our warehouse; or (ii) when a customer does not arrange their own shipping, we cannot recognize revenue until it is delivered and the customer takes “control” of the product.


This establishes a “deferred revenue” event until such time as delivery of the product has been completed and we have proof from the shipper of the delivery (and change in control).


Deferred revenue was $42,125, inclusive of $45 of shipping and handling revenue (see below), as of September 30, 2021.  Deferred revenue was $17,667, inclusive of $1,633 of shipping and handling revenue (see below), as of September 30, 2020. 

We invoice the customer at shipping, starting the accounts receivable process.  Our Company collection policies on products does not change (this includes any prepayment and credit establishment processes). Nor do our refund and return policies change where credit is provided on account for the next purchase as no refunds are given.

The result of this accounting change, and the routine December plant shut down, resulted in no deferred revenue for the period ended December 31, 2017 as all items were shipped and received by customers.

Shipping and Handling


Shipping and Handling Fees require that freight costs charged to customers be classified as revenues. Freight expenses are included in costs of sales and are recognized as incurred.  However, dueDue to our adoption of ASC 606 as discussed above, we defer the revenues of shipping and handling until the related revenue is also recognized.


The result of this accounting change, and the routine December plant shut down, resulted in nois a deferral of $45 as of December 31, 2017.September 30, 2021 and $1,633 as of September 30, 2020.


6

Table of Contents

AMERITYRE CORPORATION
Notes to the Unaudited Financial Statements
December 31, 2017

Basic and Fully Diluted Net LossIncome (Loss) Per Share

Basic and Fully Diluted net lossincome (loss) per share is computed using the weighted-average number of common shares outstanding during the period.

Our outstanding stock options and warrants and shares issuable upon conversion of outstanding convertible notes have been excluded from the basic and fully diluted net lossincome per share calculation.  We excluded 3,730,0001,030,000 and 3,800,0002,870,000 common stock equivalents for the periodsquarters ended December 31, 2017September 30, 2021 and 2016,2020, respectively, because they are anti-dilutive.


AMERITYRE CORPORATION

Notes to the Unaudited Condensed Financial Statements

September 30, 2021

Recent Accounting Pronouncements


Recently Adopted and Recently Issued Accounting Guidance

Issued

In February 2016, the FASB issued ASU No. 2016-02, “Leases”, (“ASU 2016-02”) which amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets and making targeted changes to lessor accounting. ASU 2016-02 will become effective for public companies during interim and annual reporting periods beginning after December 15, 2018 with early adoption permitted. The Company is currently evaluating the impact of the adoption of ASU 2016-02 on the Company’s financial statements.

In March 2016, the FASB issued ASU No. 2016-09, “Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting.” ASU 2016-09 amends several aspects of the accounting for share-based payment transactions including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. ASU 2016-09 is effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. Early adoption is permitted. If early adopted, an entity must adopt all of the amendments in the same period. The Company is currently evaluating the impact of the adoption of ASU 2016-09 on the Company’s financial statements.

In May 2017, the FASB issued ASU No. 2017-09, “Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting” Issued to provide clarity and reduce diversity on practice and the cost and complexity to a change in the terms and conditions of a share-based payment award. ASU 2017-09 is effective for all entities for annual periods, and interim periods within those annual periods, beginning after December 15, 2017. Early adoption is permitted, including adoption in an interim period. If an entity early adopts the amendments in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes that interim period.  The Company is currently evaluating the impact of the adoption of ASU 2016-09 on the Company’s financial statements.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC, did not, or are not believed by management to, have a material impact on the Company’sCompany's present or future financial position, results of operations or cash flows.

7

Table of Contents

AMERITYRE CORPORATION
Notes to the Unaudited Financial Statements
December 31, 2017

NOTE 3 - – INVENTORY


Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or net realizable value.  The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.

 December 31, 2017  June 30, 2017  

September 30, 2021

  

June 30, 2021

 
 (Unaudited)     

(Unaudited)

     
Raw Materials $249,264  $262,187  $444,027  $416,709 
Finished Goods  557,793   595,910   579,110   525,565 
Inventory reserve  (55,437)  (53,503)  (119,778

)

  (119,652

)

Inventory - net $751,620   804,594 

Inventory – net (current and long term)

 $903,359  $822,622 

Our inventory reserve reflects items that were deemed to be defective or obsolete based on an analysis of all inventories on hand.


In fiscal years 2018 and 2017, the

The Company critically reviewedreviews all slow moving inventory to determine if it is defective or obsolete.  If not defective or obsolete we presentedpresent these items as non-current inventory, although all inventory is ready and available for sale at any moment.  

NOTE 4 - DEBT RIGHT TO USE LEASE ASSETS


Based on our lease accounting policy, we have identified the following operating leases. As of September 30, 2021, we have no financing leases:

  

September 30, 2021

  

June 30,  2021

 
  

(Unaudited)

     

Facility lease

 $411,300  $448,200 

Leasehold improvements related to our facility

  289,604   286,854 

Accumulated amortization – leasehold improvements

  (194,431

)

  (190,984

)

Right to use leased assets, operating, net

 $506,473  $544,070 

In March 2019 we negotiated a five year extension of the lease on our executive office and manufacturing facility located at 1501 Industrial Road, Boulder City, Nevada.  The property consists of a 49,200 square foot building.  We currently occupy all 49,200 square feet, inclusive of approximately 5,500 square feet of office space, situated on approximately 4.15 acres.  Our remaining liability under this agreement is $411,300, payable at amounts ranging from $11,750 to $12,600 a month until June 30, 2024.

NOTE 5 – DEBT

A former board member, Silas O. Kines, who passed away on January 11, 2012, was also the principal owner of Forklift Tire of Florida and K-2 Industrial Tire, Inc.  In accordance with the Commission Agreement with Forklift Tire of Florida, dated February 2, 2011, between Amerityre Corporation and K-2 Industrial Tire, Inc., K-2 is due a five percent (5%) commission on all forklift tire sales.  In exchange for the forklift models transferred to Amerityre under that agreement, the first $96,000 in commission payments will be used to extinguish the long term liability recorded on the transaction.  As of December 31, 2017,September 30, 2021, $2,000 and $62,651$61,326 (June 30, 2017,2021, $2,000 and $62,940)$61,326) were recorded for the current and long-term portion, respectively, of the related liability.


In June 2016, the Company executed a term note with U.S. Bank to finance critical manufacturing equipment and operating enhancements.  Manufacturing equipment of approximately $29,000 was place in service in July 2016.  Various operating enhancement, inclusive of a website redesign, were implemented in fiscal 2017.  In the first quarter of fiscal 2018 the last operational enhancement related to a sales customer relation management (“CRM”) system was abandoned due to challenges with the selected implementation vendor.  The Company is pursuing other options to address its CRM system needs and the amount we financed for the CRM system ($15,000) through this debt instrument remains the Company’s liability to pay.  Total amount financed for the CRM system, website upgrade, and manufacturing equipment was $55,068, at 5.59% interest, with payments of $1,059 due for 60 months starting July 2016.

In July 2016, the Company executed a term note with U.S. Bank to finance critical plant facility equipment which was placed into service in July 2017.  The total amount financed was $37,666 at 5.59% interest, with payments of $720 due for 60 months starting October 2016.

  Payments due by period 
  Total  
Less than
1 year
  1 to 3 years  3 to 5 years  
After
5 years
 
    
Bank debt (both US Bank facilities above) $88,614  $21,349  $67,265  $-  $- 
                     
Total cash obligations $88,614  $21,349  $67,265  $-  $- 



AMERITYRE CORPORATION

Notes to the Unaudited Condensed Financial Statements

September 30, 2021

December 31, 2017


NOTE 5 - CAPITAL LEASE

In July 2015 the Company entered into a capital lease for research and development equipment for $19,337.

The following is a schedule by years of future minimum lease payments under capital leases together with present value of the net minimum lease payments as of December 31, 2017:

2018 $4,349 
2019  725 
2020  - 
Total minimum lease payments  5,074 
Less:  executory costs  - 
Net minimum lease payments  5,074 
Less:  amount representing interest  (345)
Present value of net minimum payments $4,729 

NOTE 6 - STOCK TRANSACTIONS, OPTIONS AND WARRANTS


On July 22, 2020, the Board of Directors adopted the 2020 Equity Incentive Plan (the “2020 Plan”) which contains provisions for up to 2,500,000 stock-based instruments to be granted to employees, consultants and directors.

Prior Issuances

On October 26, 2021, the Board of optionsDirectors adopted the 2022 Equity Incentive Plan (the “2022 Plan”) which contains provisions for up to 10,000,000 stock-based instruments to be granted to employees, consultants and directors.


On December 1, 2016, 480,000

No stock or options were granted toduring the Company’s Chief Executive Officer as part of his employment offer.  The options have a strike price of $0.10, vest December 1, 2017 and expire December 1, 2020.  Year to date expense related to these options is $729 as of December 31, 2017. fiscal quarter ended September 30, 2021 or thus far in fiscal year 2022.


A summary of the status of our outstanding stock options as of December 31, 2017September 30, 2021 and June 30, 20172021, and changes during thethese periods then ended is presented below:


 December 31, 2017  June 30, 2017  

September 30, 2021

 

June 30, 2021

 
    Weight Average  Intrinsic     Weight Average  Intrinsic  

Weighted Average

 

Intrinsic

 

Weighted Average

 

Intrinsic

 
 Shares  Exercise Price  Value  Shares  Exercise Price  Value  

Shares

 

Exercise Price

 

Value

 

Shares

 

Exercise Price

 

Value

 
Outstanding beginning of period  4,280,000  $0.12     3,800,000  $0.13    

1,030,000

 

$

0.12

   

2,870,000

 

$

0.12

  
Granted  -  $0.00       480,000  $0.10      

-

 

$

0.00

  

-

  

$

0.00

  
Expired/Cancelled  (550,000) $(0.10)      -  $0.00      

-

 

$

0.00

   

(1,840,000

)

 

$

0.12

  
Exercised  -  $0.00       -  $0.00       

-

 

$

0.00

    

-

 

$

0.00

  
Outstanding end of period  3,730,000  $0.13  $-   4,280,000  $0.12  $-   

1,030,000

 

$

0.12

 

$

-

  

1,030,000

 

$

0.12

 

$

-

 
Exercisable  3,730,000  $0.13  $-   4,080,000  $0.12  $-   

1,030,000

 

$

0.12

 

$

-

  

1,030,000

 

$

0.12

 

$

-

 



    

Outstanding

  

Exercisable

 

Range of

Exercise Prices

  

Number Outstanding

at

September 30, 2021

  

Weighted

Average

Remaining

Contractual Life

  

Weighted

Average

Exercise Price

  

Number

Exercisable at

September 30, 2021

  

Weighted

Average Remaining

Contractual Life

 

$

0.08

   

150,000

   

0.17

  

$

0.08

   

150,000

   

0.17

 

$

0.10

   

480,000

   

0.25

  

$

0.10

   

480,000

   

0.25

 

$

0.17

   

400,000

   

0.17

  

$

0.17

   

400,000

   

0.17

 
     

1,030,000

           

1,030,000

     




9

Table of Contents

AMERITYRE CORPORATION
Notes to the Unaudited Financial Statements
December 31, 2017

NOTE 6 - STOCK OPTIONS AND WARRANTS, Continued
The following table summarizes the range of outstanding and exercisable options as of December 31, 2017:

   Outstanding  Exercisable 
Range of
Exercise Prices
  
Number Outstanding
at
December 31, 2017
  
Weighted
Average
Remaining
Contractual Life
  
Weighted
Average
Exercise Price
  
Number
Exercisable at
December 31, 2017
  
Weighted
Average Remaining
Contractual Life
 
$0.08   150,000   3.92  $0.08   150,000   3.92 
$0.10   2,130,000   1.61  $0.10   2,130,000   1.61 
$0.17   1,450,000   2.92  $0.17   1,450,000   2.92 
     3,730,000           3,730,000     

NOTE 7 - – SUBSEQUENT EVENTS


On January 21, 2018, 60,000 shares wereOctober 26, 2021, the Board of Directors adopted the 2022 Equity Incentive Plan (the “2022 Plan”) which contains provisions for up to 10,000,000 stock-based instruments to be granted to the Company’s Chief Financial Officer as part her employment renewal.  The shares are valued as of January 21, 2018employees, consultants and vest ratably through December 2018.  In addition to the stock, her base compensation was adjusted to $36,000 per annum.directors.




ITEM 2. MANAGEMENT’SMANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This discussion and analysis contains statements of a forward-looking nature relating to future events or our future financial performance or financial condition.Such statements are only predictions and the actual events or results may differ materially from the results disc-useddiscussed in or implied by the forward-looking statements.Factors that could cause or contribute to such differences include, but are not limited to, those discussed in “PartPart I. Item 1A. Risk Factors”Factors as well as those discussed elsewhere in this report.The historical results set forth in this discussion and analyses are not necessarily indicative of trends with respect to any actual or projected future financial performance.This discussion and analysis should be read in conjunction with the financial statements and the related notes thereto included elsewhere in this report.

Overview

Overview


Amerityre engages in the research and development, manufacturing, and sale of solid polyurethane foam and polyurethane elastomer tires.  We believe that we have developed unique polyurethane formulations that allow us to make products with superior performance characteristics, including high abrasion resistance, increased energy efficiency, and higher load-bearing capabilities, when compared to conventional rubber tires.  We also believe that ourtires, in the areas of abrasion resistance, energy efficiency and load-bearing capabilities.  Our manufacturing processes are more energy efficient than the traditional rubber tire manufacturing processes, in part because our polyurethane compounds do not require the multiple processing steps, extreme heat, and high pressure that are necessary to cure rubber. Using our polyurethane-based technologies, weWe believe tires can be produced whichwith our proprietary polyurethane formulations last longer, are less susceptible to failure and are friendlyfriendlier to the environment. environment when compared to competitor offerings.


We concentratefocus our business on three segments of the flat free tire market: light duty polyurethane foam tires, polyurethane elastomer industrial tires and agricultural tires. Our focus continues to be applications and markets where our advantages in product technology, and tire performance, and customer service give us an opportunity to obtain premium pricing. Our most recent activities in these areasproduct development and marketing efforts are set forth below:focused on building customer relationships and expanding sales with original equipment manufacturers and tire distributors.  Our competitive advantage is creating unique product solutions for customers who have challenging tire performance requirements that cannot be met by competitor offerings.

Light Duty

Closed cell Polyurethane Foam Tires – The sale of polyurethane foam tires to original equipment manufacturers, distributors, and dealers accounts for the majority of our sales revenue. We have the ability to produce a broad range of productstire sizes for the light duty tire market. Our efforts in product developmentmarket, including bicycle tires, hand truck tires, mobility tires, lawn/garden tires, golf car tires, and marketing allow us to build customer relationships and expand sales with original equipment manufacturers and tire distributors.  We continue our focuslight industrial vehicle tires.

Despite the ongoing negative effects of COVID-19 on creating unique product solutions for customers with specific tire performance requirements. During fiscal year 2017the overall US economy, we have seen increased interestexperienced higher than expected demand for our polyurethane foam tires in the recent quarter. Sales for the fiscal first quarter 2022 were 32.3% higher than the sales level in fiscal first quarter 2021. We continue to see strong sales trends that we saw during fiscal year 2021 as our current customer base is experiencing strong sales and our domestically produced tires are attractive to those new customers looking for a domestic source for their tires

Our industrial tire product line, which includes our golf cart and baggage cartcar tires, our 480 x 12 tires, and weour 570 x 12 tires, continues to see outstanding demand in the marketplace. We expect this trend to continue in the future. In general, our international sales over the past few years have been adversely affected by the strong US dollar, but recent weakening of the US dollar indicates that this headwind may be subsiding.coming quarters.

Polyurethane Elastomer Industrial Tires ElastomerOur elastomer formulations are used to manufacture tires requiring higher levels of abrasion resistance and greater load bearing capability. Forklift tires constitute a large part of this market, with other industrial tires contributed negligible revenue during the quarter.  During the fourth quarter of fiscal year 2016 we relaunched the forklift tire product line with select customers. The slow acceptanceand agricultural applications representing other opportunities. Overall sales volumes of our forklift tires remain small, less than 0.1% of our total sales revenue. Price sensitive consumers continue to favor imported solid rubber press-on forklift tires rather than our products, and we have not devoted significant resources towards promoting this product line.We have been working with original equipment manufacturers (“OEMs”) to utilize our elastomer formulations for large industrial equipment tires and agricultural applications, which may lead to new revenue sources in the marketplace continued duringfuture.

Light Density Elastomer Tires – Demand for our light density elastomer formulation (ElastothaneTM 500) in applications requiring greater abrasion resistance and load bearing capability than our polyurethane foam tires. Lawn and garden tire applications continue to drive increased sales of this formulation, although we have seen some custom tire applications for this formulation as well. We expect Agricultural tires sales to continue to increase in the recent quarter.   Our scissor lift tire also continuescoming quarters as farmers are seeing higher levels of disposable income than they have in years. However, economic challenges such as supply shortages could limit anticipated benefits or our ability to experience limited interest as OEMs have to date not approved the use of the tire as a replacement for their current offering.capitalize on them. We continue to utilizeapproach OEMs and large distributors about promoting and utilizing our researchtires for certain applications, and development resources to develop new elastomers that may offer specific advantages in certain tire applications. several are evaluating sample tires.

We have made identification of new customers for our elastomer products a key component of our sales/marketing plan. We continue to have discussions with various potential end-users and eventually expect some of these discussions to translate into higher sales


Agricultural Tires – Sales of agricultural tires during the quarter continue to be negatively impacted by low farm commodity prices, which have reduced farm income levels and funds available for the purchase of farm equipment. In previous years we have seen large “end of year” purchases before the end of the calendar year, but this did not occur during the recent quarter. Recent discussions with farmers indicate that farm commodity pricing is expected to remain challenged for calendar year 2018. Therefore, we are expecting continued difficult conditions for agricultural tire sales. We will continue our marketing efforts to educate the agricultural market about our products. We also expect to launch a new hay baler tire in the coming months that will improve tire durability in the field compared with our current tire.

Due to the Company’s limited resources, tire projects which are contingent on additional significant development have been put on hold. However, we continue to supportbelieve investment in R&D for new and improved products as anis important component ofto the continued turnaround ingrowth and success of our overall business, and we will selectively invest in promising opportunities that fitcan be supported within our current financial model. We have several product evaluations programs ongoing which have the potential to develop into significant future business. We expect our current R&D investments to continue to prove to be a prudent investment of our capital resources.

A major component of our strategic operating plan is to establish a partnership or other type of business combination with a larger OEM or tire manufacturer who would have a larger distribution channel as well as financial resources to fully leverage our current tire portfolio as well as new products that can be developed using our formulations. The wide availability of capital in the markets has increased the amount of equity investment and merger/acquisition activity in the market. We are open to discussions and will continue to pursue opportunities that we believe will maximize the potential of our intellectual property and the overall value of the business.

We continue to face supply chain issues and increases in raw material and operating costs which we expect will continue to pressure our Gross Profit Margins. We implemented another price increase in August 2021 on our tire assemblies to mitigate the effects of these increases in our current budget. These effortscosts. However, as evidenced by our lower Gross Margins for the quarter, the price increases were not successful at offsetting all cost increases during the quarter. We will continue to closely manage the cost drivers of our business and take appropriate corrective actions, including further price increases where warranted.

Our sales growth over the past year has been very strong. However, it is unclear if the environment of rising costs and the corresponding higher sales prices will affect demand for our products moving forward. Raw material availability is also expected to continue to be an issue in the upcoming quarters as the existing supply chain issues are primarily targetedbeing resolved. While we continue to have a very strong backlog of business, we may be restricted as to how much product we can produce if raw material is not available on developing improved ng polyurethane formulations for specific tire applicationsa timely basis. We are in constant contact with our target markets.suppliers to ensure that negative supply impacts are minimized, although in some cases this may result in Amerityre incurring higher material costs. 


11

Table of Contents

Our

As described above, our product line covers diverse market segments which are unrelated in terms of customer base, product distribution, market demands and competition. Our sales team is comprised of our in-house sales department supplemented by three independent manufacturer representatives.representatives with inside sales support. The Company’s continued emphasis on proper product pricing and new marketing campaigns continues to drive more sales, as shown by our increase in sales revenue in the first half of  fiscal year 2018 versus the same period in fiscal year 2017.profitable sales. Our upgraded website continues to educateeducates the marketplace about our products as well as generate someoffers an outlet for online sales. We have a solid backlog for orders to be delivered over the next 12 months. We continue to pursue relationships with large distributors and original equipment manufacturers in key market segments. These relationships will bring additional exposure for Amerityre products in the marketplace and lead to increased sales. Our future marketing activities will continue to target higher growth market segments and other opportunities where our premium performance products can address the needs of customers with unique applications.


During the recent quarter our gross margins began to be impacted by higher raw material costs. These increases were driven by an overall reduction of available material in the market due to increased economic activity as well as Southwest suppliers recovering from storm damage to their manufacturing facilities. We expect elevated raw material costs to negatively affect gross margins going forward. We will attempt to mitigate these cost pressures by qualifying alternative supply sources to create a competitive situation when purchasing raw materials. We continue to work on development of new formulations that utilize less expensive raw materials while providing the same level of superior performance that defines our products.  We are also considering the implementation of price increases on our finished products in the event raw material prices cannot be offset adequately by cost reduction measures.

Factors Affecting Results of Operations

Our operating expenses consisted primarily of the following:


Cost of sales, which consists primarily of raw materials, components and production of our products, including applied labor costs and benefits expenses, maintenance, facilities and other operating costs associated with the production of our products;

Cost of sales, which consists primarily of raw materials, components and production of our products, including applied labor costs and benefits expenses, maintenance, facilities and other operating costs associated with the production of our products;


Selling, general and administrative expenses, which consist primarily of salaries, commissions and related benefits paid to our employees and related selling and administrative costs including professional fees;

Selling, general and administrative expenses, which consist primarily of salaries, commissions and related benefits paid to our employees and related selling and administrative costs including professional fees;


Research and development expenses, which consist primarily of  direct labor conducting research and development, equipment and materials used in new product development and product improvement using our technologies;

Research and development expenses, which consist primarily of  direct labor conducting research and development, equipment and materials used in new product development and product improvement using our technologies;


Consulting expenses, which consist primarily of amounts paid to third-parties for outside services;

• Consulting expenses, which consist primarily of amounts paid to third-parties for outside services;


Depreciation and amortization expenses which result from the depreciation of our property and equipment, including amortization of our intangible assets; and

•  Depreciation and amortization expenses which result from the depreciation of our property and equipment, including amortization of our intangible assets; and


Stock based compensation expense related to equity awards issued to directors, employees and consultants for services performed for the Company.

• Stock based compensation expense related to stock and stock option awards issued to employees and consultants for services performed for the Company.


Critical Accounting Policies


Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with United States generally accepted accounting principles.  The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses.  On an ongoing basis, we evaluate our estimates, including those related to uncollectible receivables, inventory valuation, deferred compensation and contingencies.  We base our estimates on historical performance and on various other assumptions that we believe to be reasonable under the circumstances.  These estimates allow us to make judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.


We believe the following accounting policies are our

At present we do not have any critical accounting policies because they are important to the portrayal of our financial condition and results of operations and theythat require critical management judgments and estimates about matters that may be uncertain.  If actual results or events differ materially from those contemplated by us in making these estimates, our reported financial condition and results of operations for future periods could be materially affected.


Revenue Recognition

The majority of our revenue is derived from short-term sales contracts. We account for revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers”, which we adopted on July 1, 2017, using the modified retrospective method.

Revenue for our products is recognized at the time in which our performance obligation is satisfied which we have defined as “control” of the product by the customer. “Control” is defined as a customer having “rights/obligations of physical control over the product or has the rights and intention to control the product.” Based on the terms of our contracts, a customer’s “control” is based on analysis of the following; (i) when a customer arranges their own shipping, and once the product has left our dock, Amerityre recognizes revenue for the product.  In effect by arranging their own shipping the customer is “taking control” of the product when it leaves our warehouse; or (ii) when a customer does not arrange their own shipping we cannot recognize revenue until it is delivered and the customer takes “control” of the product.

This establishes a “deferred revenue” event until such time as delivery of the product has been completed and we have proof from the shipper of the delivery (and change in control).

We invoice the customer at shipping, starting the accounts receivable process.  Our Company collection policies on products does not change (this includes any prepayment and credit establishment processes). Nor do our refund and return policies change where credit is provided on account for the next purchase as no refunds are given.

The result of this accounting change, and the routine December plant shut down, resulted in no deferred revenue for the period ended December 31, 2017 as all items were shipped and received by customers.

Shipping and Handling

Shipping and Handling Fees require that freight costs charged to customers be classified as revenues. Freight expenses are included in costs of sales and are recognized as incurred.  However, due to our adoption of ASC 606 as discussed above, we defer the revenues of shipping and handling until the related revenue is also recognized.

The result of this accounting change, and the routine December plant shut down, resulted in no deferral as of December 31, 2017.

Valuation of Intangible Assets and Goodwill

Patent and trademark costs have been capitalized at December 31, 2017, totaling $487,633 with accumulated amortization of $343,598 for a net book value of $144,036. Patent and trademark costs capitalized at December 31, 2016, totaled $479,633 with accumulated amortization of $317,902 for a net book value of $161,731.

The patents which have been granted are being amortized over a period of 20 years. Patents which are pending or are being developed are not amortized. Amortization begins once the patents have been issued. As of December 31, 2017 and 2016, respectively, there were no pending patents.  Annually, pending or expired patents are inventoried and analyzed, which resulted in the recognition of a loss on abandonment, expiration or retirement of patents and trademarks of $-0- for each of the periods ended December 31, 2017 and 2016, respectively.

Amortization expense for the six months ended December 31, 2017 and 2016 was $11,916 and $6,499 respectively.  The Company evaluates the recoverability of intangibles and reviews the amortization period on a continual basis utilizing the guidance of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 350, Intangibles – Goodwill and Other.  We consider the following indicators, among others, when determining whether or not our patents are impaired:
any changes in the market relating to the patents that would decrease the life of the asset;

any adverse change in the extent or manner in which the patents are being used;

any significant adverse change in legal factors relating to the use of the patents;

current period operating or cash flow loss combined with our history of operating or cash flow losses;

future cash flow values based on the expectation of commercialization through licensing; and

current expectations that, more likely than not, the patents will be sold or otherwise disposed of significantly before the end of its previously estimated useful life.

13

Table of Contents

Inventory
Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or market. The cost of finished goods includes the cost of raw material, direct and indirect labor, and other indirect manufacturing costs. The inventory consists of chemicals, finished goods produced in the Company’s plant and products purchased for resale.

Stock-Based Compensation
We account for stock-based compensation under the provisions of FASB ASC 718, Compensation – Stock Compensation.  Our financial statements as of and for the six months ended December 31, 2017 and 2016, respectively, reflect the impact of FASB ASC 718. Stock-based compensation expense recognized under FASB ASC 718 for the six months ended December 31, 2017 and 2016 was $14,191 and $15,223, respectively, related to employee stock options and employee stock grants.

FASB ASC 718 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our Statement of Operations. Stock-based compensation expense recognized in our Statements of Operations for six months ended December 31, 2017 and 2016, respectively assume all awards will vest; therefore no reduction has been made for estimated forfeitures.

Results of Operations

Our management reviews and analyzes several key performance indicators in order to manage our business and assess the quality and potential variability of our sales and cash flows.  These key performance indicators include:

Revenues, net of returns and trade discounts, which consists of product sales and services and is an indicator of our overall business growth and the success of our sales and marketing efforts;

•  Revenues, net of returns and trade discounts, which consists of product sales and services and is an indicator of our overall business growth and the success of our sales and marketing efforts;

Gross profit, which is an indicator of both competitive pricing pressures and the cost of goods sold of our products and the mix of product and license fees, if any;

•  Gross profit, which is an indicator of both competitive pricing pressures and the cost of goods sold of our products and the mix of product and license fees, if any;

Growth in our customer base, which is an indicator of the success of our sales efforts; and

•  Growth in our customer base, which is an indicator of the success of our sales efforts; and

Distribution of sales across our products offered.

•  Distribution of sales across our products offered.

The Company, in light of the impact COVID-19 has had on our business, implemented a price increase on most of its products starting on April 1, 2021. We have seen over the past 10 months significant increases in raw material pricing, caused in part due to supply chain disruptions arising from the COVID-19 pandemic. The January 2021 winter storms in Texas took all polyol manufacturing offline for several weeks as these facilities needed to be repaired and brought back online. Combined with COVID-19-related reductions in propylene manufacturing capacity, the Company was fortunate to receive enough material to maintain operations, albeit at significantly higher prices and an amount that limited our ability to fulfill orders on a timely basis. Shortages of other raw materials in the chemical markets may continue or increase in the coming months, and it is therefore not clear that raw material pricing will return to the lower levels of 2020, or even stabilize at current elevated levels. Management continues to monitor the situation and is prepared to make further product pricing adjustments if necessary. The following paragraphs address these factors and the effects on our business during the fiscal quarter ended September 30, 2021.

The following summary table presents a comparison of our results of operations for the fiscal quarters ended December 31, 2017September 30, 2021 and 20162020 with respect to certain key financial measures.  The comparisons illustrated in the table are discussed in greater detail below.

 
For the Three Months Ended
December 31,
     
For the Six Months Ended
December 31
     

Three Month Period Ended September 30,

  

Percent Change

 
 (in 000’s)  Change  (in 000’s)  Change  

(in 000’s)

     
 2017  2016  2017 vs. 2016  2017  2016  2017 vs. 2016  

2021

  

2020

  

2021 vs. 2020

 
Net revenues $867  $879   (1.4%) $1,793  $1,716   4.5% $1,396  $1,051   32.8

%

Cost of revenues  (592)  (612)  (3.3%)  (1,244)  (1,168)  6.5%  (1,011

)

  (708

)

  42.8

%

Gross profit  275   267   2.7%  549   548   0.1%  385   343   11.9

%

Research and development expenses  (53)  (56)  (5.7%)  (111)  (109)  1.9%  (22

)

  (20

)

  10.0

%

Sales and marketing expense  (50)  (59)  (15.9%)  (115)  (126)  (8.7%)  (68

)

  (60

)

  13.3

%

General and administrative expense  (173)  (147)  17.5%  (368)  (339)  8.6%  (233

)

  (210

)

  10.4

%

Loss on asset abandonment  -   -   0.0%  (17)  -   100.0%
Other income (expense)  (2)  (2)  0.0%  (4)  (5)  (20.0%)
Net income (loss)  (3)  3   (200.0%)  (65)  (31)  106.9%
Preferred stock dividend  (25)  (25)  0.0%  (50)  (50)  0.0%
Net loss attributable to common shareholders $(28) $(22)  24.3% $(115) $(81)  42.0%

Loss on asset disposal

  -   (3)  (100.0

)%

Other income

  3   4   (25.0

)%

Net income (loss) attributable to common shareholders

 $65  $54   20.4

%

14

Table of Contents

Three Months

Quarter Ended December 31, 2017September 30, 2021 Compared to December 31, 2016September 30, 2020


Net Sales.Revenues.  Net salesrevenues of $866,944$1,395,614 for the quarter ended December 31, 2017,September 30, 2021, represents a 1.5% decrease compared toan 32.8% increase over net salesrevenues of $879,607$1,051,286 for the same period in 2016.2020. These results were in line withexceeded our expectations. Our sales were again driven primarilyexpectations as we continued to navigate the challenges presented by closed cell foam tire sales.  Our forecast for the remainder of fiscal 2017 anticipates continued challenging sales in the agricultural tire market, due to low commodity prices adversely affecting farm income.  While we are working on several new initiatives utilizing our elastomer technology, which may increase sales in the industrial tire segment, weCOVID-19 pandemic, including limited raw material availability, higher supply costs and other supply chain issues. We expect our polyurethane foam products to continue to constitute the majority of our sales during the remaindergoing forward.

Cost of Revenues.  Cost of revenues for the quarter ended December 31, 2017September 30, 2021 was $592,336$1,010,842 or 68.3%72.4% of sales compared to $612,336$707,566 or 69.6%67.3% of sales for the same period in 2016. Cost of revenues varied due to product mix differences between the two periods, with more profitable products being sold in2020. We experienced higher raw material costs, particularly chemical feedstocks, during the recent quarter versuswhich pressured gross profit margins. Our chemical suppliers have informed us that there will likely be continued price increases in the prior period.   As mentioned earlier,coming months due to a slow recovery in manufacturing capacity for our raw materials as well as increased market demand. The supply chain issues in procuring material from China has caused higher costs and long delays for our steel rims. We expect these headwinds to continue to pressure our Gross Margins throughout fiscal year 2022. We have mitigated some of these issues by increasing the sales prices of our tires. However, continuing increases in raw material costs may result in reduced product sales if we are forced to turn away sales because they are at price increaseslevels that are expected to become a major headwind moving forward in FY 2018, putting pressure on our gross margins.unprofitable.


Gross Profit.  Gross profit for the quarter ended December 31, 2017September 30, 2021 was $274,609$384,772 compared to $267,271$343,720 for the same period in 2016. Gross profit for the quarter ended December 31, 2017 increased by $7,3382020, an increase of $41,052 or 2.7% over11.9% ,over the same period in 2016 due to the decrease in the cost of revenue. .2020.   The December 31, 2017September 30, 2021 gross profitmargin reflects a 31.7%27.6% gross margin foron product sales compared to a gross margin on product sales of 30.4%32.7% in 2020. The lower gross profit is the quarter ending December 31, 2016.result of higher raw material costs and higher shipping costs on materials purchased from overseas.

Research & Development Expenses (R&D).  Research and development expenses for the quarter ended December 31, 2017September 30, 2021 were $53,002$21,567 compared to $56,185$20,471 for the same period in 2016.2020. We continue to focus our R&D efforts oninvest in product formulation optimization and new product development.  The Company plansdevelopment where appropriate to continue this level of expenditure as R&D is a key component of the company’ssupport our business improvement initiatives.plan.

Sales & Marketing Expenses. Sales and marketing expenses for the quarter ended December 31, 2017September 30, 2021 were $49,583$68,373 as compared to $58,961$59,800 for the same period in 2016. Sales and marketing expenses decreased $9,3782020. The difference between periods primarilyreflects higher commission expenses paid during the recent period due to lower paid commissions and travel costs.higher sales volumes.


General & Administrative Expenses.  General and administrative expenses for the quarter ended December 31, 2017September 30, 2021 were $173,328$232,848 compared to $147,477$210,486 for the same period in 2016. This increase of $25,851 between periods is2020, driven by increases in salaries, consultant fees, audit fees,higher compensation costs. We continue to control costs and repairs in the current quarter versus the same period in 2016find more efficient ways to conduct our business activities.


Other Expense.Income, net.  Other expenseincome for the quarter ended December 31, 2017September 30, 2021 was $1,265$3,116 compared to $1,832other income of $820 for the same period in 2016. Other expense consists solely of interest expense and increased in the period due to our new bank debt facilities.2020.

Net (Loss) Income.  Net lossincome for the quarter ended December 31, 2017 was $2,569,September 30, 2021 of $65,100 compared to a net profit of $2,816 for the quarter ended December 31, 2016


Six Months Ended December 31, 2017 Compared to December 31, 2016

Net Sales.  Net sales of $1,792,660 for the six months ended December 31, 2017, represents a 4.5% increase over net sales of $1,715,760$53,783 for the same period in 2016. These results were2020. This represents 20.4% increase in line with our expectations. Our sales were primarily sales of closed cell foam tire sales, with sales of agricultural and industrial tires being negligible during the period. We continue to have a positive response to our marketing and pricing plans for our polyurethane foam tires, although sales in key markets such as the agriculture market continue to be depressed due to low commodity pricing.
Cost of Revenues.  Cost of revenues for the six months ended December 31, 2017 was $1,244,153 or 69.4% of salesnet income compared to $1,167,788 or 68.1%the first quarter of sales for the same period in 2016. Product mix differences between the two periods is the major factor affecting cost of revenue  fiscal year 2021of $11,317.


Gross Profit.  Gross profit for the six months ended December 31, 2017 was $548,508 compared to $547,972 for the same period in 2016.  The December 31, 2017 gross profit reflects a 30.6% gross margin for product sales compared to a gross margin on product sales of 31.9% in 2016.
Research & Development Expenses (R&D).  Research and development expenses for the six months ended December 31, 2017 were $111,143 compared to $109,044 for the same period in 2016.
15

Table of Contents

Sales & Marketing Expenses. Sales and marketing expenses for the six months ended December 31, 2017 were $115,318 as compared to $126,191 for the same period in 2016. Sales and marketing expenses decreased $10,873 between periods primarily due to the payment of lower sales commission payments and lower travel costs, offset by increased trade show expenses as we attended two trade shows during this six month period.

General & Administrative Expenses.  General and administrative expenses for the six months ended December 31, 2017 were $368,279 compared to $339,783 for the same period in 2016. The increase in General and administrative expenses of $28,496 between periods is driven by the factors discussed previously for the Q2 Fiscal Year 2018 variance

Other Expense.  Other expense for the six months ended December 31, 2017 was $19,992 compared to $4,964 for the same period in 2016. Other expense consists of loss on the abandonment of fixed assets in relation to a failed CRM implementation and interest expense on our bank debt facilities. 

Net Loss.  Net loss for the six months ended December 31, 2017 of $66,224 represents a 106.9% increase from the net loss for the six months ended December 31, 2016 of $32,010.  

Liquidity and Capital Resources

Our principal sources of liquidity consist of cash and payments received from our customers.  We do not have any significant revolving credit arrangements.  Historically, our expenses have exceeded our sales, resulting in operating losses.  From time to time, we have obtained additional liquidity to fund our operations through the sale of shares of our common stock and the placement of short-term debt instruments.  At the end of 2016, we were able to obtain term bank debt financing to finance critical manufacturing equipment and operating enhancements, the majority of which was placed in service in fiscal year 2017.  Management continues to evaluate financing options but is choosing to delay financing at terms that subject the Company to high costs of debt and we are reluctant to raise money through stock sales at what we believe are highly dilutive share prices.  Additionally, management has notified our preferred shareholder that we are suspending future payments of their preferred cash dividend payments, so the Company can increase its working capital levels.

We have historically not succeeded in establishing favorable revolving short term financing such as lines of credit. In the quarter ended March 31, 2015, we entered into a short term receivable factoring agreement with a third party to sell our receivable invoices.  This agreement enables us to sell individual customer invoices for faster cash flow to the Company as we deem needed. As of December 31, 2017, we have not needed to activate this financing option due to increased focus on adherence to established collection policies and proactive communication with repeat customers, including adjusting credit limits to allow for increased sales volume where warranted.

Cash Flows

The following table sets forth our cash flows for the quarters ended December 31, 2017September 30, 2021 and 2016.2020.

  

Periods ended Sept. 30,

 
  

(in 000’s)

 
  

2021

  

2020

 

Net cash provided (used) by operating activities

 $94  $(48

)

Net cash used by investing activities

  (134

)

  - 

Net cash used by financing activities

  -   - 

Net increase (decrease) in cash during the period

 $(40

)

 $(48

)

The Company has evaluated its current cash position relative to its cash requirements in the future and has determined its cash levels are sufficient to cover its cash needs. The Company enjoys a strong level of cash on hand as well as an unused credit line facility. These cash resources have been critical during the past year as working capital needs have increased due to the extended time required to receive imported materials (which are paid for when they are ready to ship from the manufacturer, not after they are received for use by the Company) as well as Management’s decision to increase chemical stock levels when extra material became available for purchase. The Company completed its upgrade of its Production pouring systems in September 2021, which was completely paid from cash reserves.

13
  Six Months ended Dec. 31, 
�� (in 000’s) 
  2017  2016 
Net cash (used) provided by operating activities $(191) $51 
Net cash used in investing activities  (6)  (11)
Net cash used by financing activities  (13)  (9)
Net (decrease) increase in cash during the period $(210) $31 

Net Cash Used by Operating Activities.

Our primaryprincipal sources of operatingliquidity consist of cash duringon hand and payments received from our customers. In February 2020, the period ended December 31, 2017 came from collections from customers, however, our period end receivables balance increased as we waited for several large customers to remit payment in early January 2018. Our primary useCompany secured a $50,000 line of operating cash was an increase in prepaid and other current assets, specifically related to renewal of insurance policies.  Net cash used by operating activities was $191,242 for the period ended December 31, 2017 compared to net cash provided by operating activities of $51,497 for the same period in 2016. 


Non-cash items include depreciation and amortization and stock based compensation.  Our net loss was $66,224 for the period ended December 31, 2017 compared tocredit with a net loss of $32,010 for the same period in 2016.  The net loss for the period ended December 31, 2017 included non-cash expenses for depreciation and amortization of $44,467 and stock-based compensation of $14,191.local community bank. As of December 31, 2016, depreciation and amortization was $52,782 and stock-based compensation (both stock issued and options) totaled $15,223.September 30, 2021, this credit line had not been used.

16

Table

Historically, the current management team has been reluctant to pursue financing at terms that subject the Company to the high costs of Contents


Net Cash Used by Investing Activities.  Net cash used by investing activities was $6,062 fordebt, or raise money through the period ended December 31, 2017 and $11,424 forsale of equity at prices we believe do not reflect the same period in 2016.  Intrue value of the recent quarter we purchased new production mold tooling. For the period ended December 31, 2016 we purchased critical facility equipment of which $11,424 was paid in cash the remainder financed through bank financing.  Company. 


Net Cash Used by Financing Activities.  Net cash used by financing activities was $12,497 for the period ended December 31, 2017 and $8,574 for the same period in 2016. The primary use of cash for the period ended December 31, 2017 was payment toward the capital lease of $3,638 and payment of notes payable of $8,859.
Contractual Obligations and Commitments
The following table summarizes our contractual cash obligations and other commercial commitments at December 31, 2017.
  Payments due by period 
  Total  
Less than
1 year
  1 to 3 years  3 to 5 years  
After
5 years
 
    
Facility lease (1) $345,000  $138,000  $207,000  $-  $- 
Capital lease (2)  4,755   4,755   -   -   - 
Bank debt (3)  88,614   21,349   67,265   -   - 
Total contractual cash obligations $438,369  $164,104  $274,265  $-  $- 

(1)In May 2015, we negotiated a five (5) year extension of the lease on our executive office and manufacturing facility located at 1501 Industrial Road, Boulder City, Nevada.  The property consists of a 49,200 square foot building.  We currently occupy all 49,200, inclusive of approximately 5,500 square feet of office space, situated on approximately 4.15 acres.  All other terms and conditions of the building lease remain in effect.
(2)In July 2015 we entered into a capital lease for research and development equipment for $19,337.
(3)In June and July 2016, in two separate bank promissory notes, we financed critical manufacturing and facility equipment and operating enhancements, the majority of which was placed in service in fiscal year 2017.

Cash Position, Outstanding Indebtedness and Future Capital Requirements

At February 9, 2018,November 10, 2021, our total cash balance was $305,209,$400,035, none of which is restricted; accounts receivables was $305,209;$474,123; and inventory, net of reserves for slow moving or obsolete inventory, and other current assets was $871.377.$779,907. Our total indebtedness, specifically which management reviews for cash management, was $557,007$774,243 and includes $298,848$324,217 in accounts payable and accrued expenses, $16,962$2,000 in current portion of long-term debt, $4,112 in capital lease liability and $115,133$61,326 in long-term debt.debt and $386,700 in total operating lease liability.

We have been working during the past yearcontinue to take actions to improve our liquidity and access to capital resources. In order to fully execute the annual strategic business plan discussed during our shareholder meeting in November 2017, we required more capital resources. However, managementManagement continues to maintain that an equity financing atin the current market conditionsenvironment would be too dilutive and not in the best interests of our shareholders. We will continue to pursue potential opportunities to secure short-term loans, long-term bank financing, revolving lines of credit with banking institutions and equity based transactions with interested financial firms and strategic industry partnershave been successful in our effort to improve the Company’s financial position and enhance shareholder value.


The Company currently does not have an existing revolving credit facility. At the end of 2016 we were able to obtain term bank debt financing to finance critical manufacturing equipment and operating enhancements.  The majority of these improvements were placed in service during fiscal year 2017. We continue to work with our vendors to obtain extended credit terms and increase credit lines where needed. Additionally, we continue to focus on adherence to established collection policies and proactive communication with repeat customers, including adjusting credit limits to allow for increased sales volume where warranted.
We are intent on focusing on the sale and distribution of profitable product lines. Management continues to look for further financing facilities at affordable terms that will allow the Company to maintain sufficient raw material and finished goods inventory to capitalize on sales growth opportunities. We are limiting our capital expenditures to that required to maintain current manufacturing capability or support key business initiatives identified in our strategic sales plan.  We continue to work to reduce our overall costs wherever possible.
17

Table of Contents

To help address our cash resources, which at times may be limited, we have held discussions with banks and other lenders regarding establishingsecuring a line of credit for short term cash needs. However at this time we have not succeeded in establishing such a line of credit.  We have entered into a short term receivable factoring agreement with a third party to sell our receivable invoices.  This agreement enables us to sell individual customer invoices for faster cash flow to the Company as we deem needed. During fiscal year 2018 we have not had the need to utilize any factoring of our invoices.bank.


Management continues to execute its strategic plan focusing on “Profitability as a Mindset”.  The Company’s emphasis on proper product pricing and new marketing campaigns has driven more profitable sales. While we are beginning to see adverse effects on our business due to an increase in raw material prices and other costs, our continued emphasis on cost control and sales at a profitable price level will enable the Company to be successful in this competitive market environment. The Company achieved full year profitability in fiscal year 2017, and this can be attributed to our “Profitability as a Mindset” initiative. A review of our strategic plan has led management to conclude that the identification of key partners who can provide better access and distribution in our target markets is required. We will continue to pursue relationships with larger partners who can help us reach the potential of our current products as well as leverage our other intellectual property into value adding products for Amerityre shareholders.

In assessing our liquidity, management reviews and analyzes our current cash, accounts receivable, accounts payable, capital expenditure commitments, cash requirements and other obligations.  In connection with the preparation of our financial statements for the periodfiscal year ended December 31, 2017,June 30, 2021, we have analyzed our cash needs for the next twelve months. We have concluded that our available cash and accounts receivables are sufficient to meet our current minimum working capital, capital expenditure and other cash requirements for this period.  However,Although we have seen a significant increase in business activity in recent quarters, there can be no assurance that a resurgence of the COVID-19 virus will not cause a disruption in our markets that causes a significant decrease in demand from our customers. While many government restrictions have been relaxed and the economy has continued to expand manufacturingopen in more jurisdictions, the emergence of new variants of COVID-19 may lead to possible resurgences of the virus. This could result in new restrictions on our customers located or servicing these affected jurisdictions. Among the adverse consequences caused by the pandemic have been continued supply chain disruptions, resulting in material shortages and sales operations beyonddelays, as well as increased material costs. The long-term financial impact on our business cannot be reasonably estimated at this time. As a result, the current level, additionaleffects of COVID-19 may not be fully reflected in our financial results until future periods. Refer to “Item 1A — Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2021 for a description of the material risks that the Company currently faces including in connection with COVID-19. If there is a new shutdown of the economy, reduction in demand for our products or other adverse effect on our business, we may lack sufficient working capital may be required.to meet our needs for the next 12 months.


The Company has, on occasion, instituted initiatives to incentivize sales of slower movingslower-moving inventory through promotional pricing. These programs will continue to be selectively utilized in the upcoming quarters to monetize inventory, promote individual product lines, and improve our cash flow.


As of February 14, 2018,November 12, 2021, the Company has approximately 3,616,00023,427,000 shares authorized and available for issuance. Although we are reluctant to raise money through stock sales at what we believe are dilutive share prices, these authorized but unissued and unreserved shares of our common stock can be utilized, if necessary, to fund the expansion of our manufacturing operations or to obtain additional working capital.raise new funds.


Off-Balance Sheet Arrangements

We do not currently have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. In addition, we do not engage in trading activities involving non-exchange traded contracts.



Cautionary Note Regarding Forward Looking Statements

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding economic conditions in general and in the agricultural market, in particular, positive sales trends and resulting profits, our intention to seek out and engage in a partnership or other arrangement with one or more OEMs, our sales prospects in light of new products such as the potential development of tires for large industrial and agricultural equipment, price increases in response to increases in raw material costs and the availability of capital and liquidity. All statements other than statements of historical facts contained in this report, including statements regarding our future financial position, liquidity, business strategy and plans and objectives of management for future operations, are forward-looking statements. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs.

These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in our Annual Report on Form 10-K for the fiscal year ended June 30, 2021. In addition, there is a risk that the economic repercussions from COVID-19 and supply chain disruptions may be more severe or prolonged than we currently expect, particularly with the new strains emerging and the uncertainty if existing vaccinations will be effective against the new strains, and vaccine hesitancy. Additionally, there is a risk that our price increases or other challenges we face and actions we take in response may result in lower revenues, or that any strategic partnerships or business arrangements do not yield the positive results intended or result in unanticipated adverse consequences, including due to potential friction between the parties. New risk factors emerge from time-to-time and it is not possible for us to predict all such risk factors, nor can we assess the impact of all such risk factors on our business or the extent to which any risk factor, or combination of risk factors, may cause actual results to differ materially from those contained in any forward-looking statements. Except as otherwise required by applicable laws, we undertake no obligation to publicly update or revise any forward-looking statements described in this report, whether as a result of new information, future events, changed circumstances or any other reason after the date this report is filed.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.


We are exposed to changes in prevailing market interest rates affecting the return on our investments but do not consider this interest rate market risk exposure to be material to our financial condition or results of operations.  We invest primarily in United States Treasury instruments with short-term (less than one year) maturities.  The carrying amount of these investments approximates fair value due to the short-term maturities.  Under our current policies, we do not use derivative financial instruments, derivative commodity instruments or other financial instruments to manage our exposure to changes in interest rates or commodity prices.

ITEM 4. CONTROLS AND PROCEDURES


The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.


As required by SEC Rule 13a-15(b), an evaluation was performed under the supervision and with the participation of our management, including our Chief Executive and Financial Officer,Officers, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the design and operation of these disclosure controls and procedures were effective at the reasonable assurance level.


Duelevel as of the end of the period covered by this quarterly report to ensure the information required to be disclosed by us in reports is timely recorded, processed, summarized and reported in accordance with the SEC’s rules and forms and communicated to our adoption of Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers”, we changed our accounting softwaremanagement as appropriate to automatically defer revenue recognition and we daily review shipping notifications for which customers have received their product, and we can therefore recognize revenue.  Other than the above, there has been no change in our internal controls over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.allow timely decisions regarding required disclosure.


PART II - OTHER INFORMATION

ITEM 1.LEGAL PROCEEDINGS

None.

ITEM 1.  LEGAL PROCEEDINGS

None.

ITEM 1A. RISK FACTORS


For information regarding risk factors, see “Part I. Item 1A. Risk Factors,” in our 2021 Annual Report on Form 10-K for the year ended June 30, 2017.Report.


ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.


None.

ITEM 3.DEFAULTS UPON SENIOR SECURITIES

None.


None.

ITEM 4.MINE SAFETY DISCLOSURES


Not applicable.


ITEM 5.OTHER INFORMATION

Our Annual Stockholders’ Meeting is scheduled for 10:00 am, Pacific Time on Wednesday, December 1, 2021 virtually. For more information about the Annual Stockholders’ Meeting, see the Company’s Definitive Proxy Statement on Schedule 14A which was filed with the Securities and Exchange Commission and mailed to our stockholders of record on October 22, 2021.

ITEM 5.  OTHER INFORMATION

None.

ITEM 6.EXHIBITS

31.1
    

Incorporated by Reference

 

Filed or Furnished

Exhibit #

 

Exhibit Description

 

Form

 

Date

 

Number

 

Herewith

3.1

 

Articles of Incorporation of the Company

 

8-A12G

 

10/28/02

 

3.01

  

3.2

 

Certificate of Amendment to the Articles of Incorporation of the Company

 

8-A12G

 

10/28/02

 

3.01

  

3.3

 

Certificate of Amendment to the Articles of Incorporation

 

10-Q

 

2/14/13

 

3(i)

  

3.4

 

Certificate of Amendment to the Articles of Incorporation

 

8-K

 

6/1/20

 

3.1

  

3.5

 

Bylaws of the Company

 

8-K

 

9/25/13

 

3.02

  

31.1

 

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

       

Filed

31.2

 

Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

       

Filed

32.1

 

Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

       

Filed

32.2

 

Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

       

Filed

101 INS

 

XBRL Instance Document

        

101 SCH

 

XBRL Taxonomy Extension Schema Document

       

Filed

101 CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document

       

Filed

101 DEF

 

XBRL Taxonomy Extension Definition Linkbase Document

       

Filed

101 LAB

 

XBRL Taxonomy Extension Label Linkbase Document

       

Filed

101 PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document

       

Filed

104

 

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

        

31.2
32.1
32.2
101 INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101 SCHXBRL Taxonomy Extension Schema Document
101 CALXBRL Taxonomy Extension Calculation Linkbase Document
101 DEFXBRL Taxonomy Extension Definition Linkbase Document
101 LABXBRL Taxonomy Extension Label Linkbase Document
101 PREXBRL Taxonomy Extension Presentation Linkbase Document

SIGNATURES


Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Dated:  February 14, 2018November 15, 2021

AMERITYRE CORPORATION

   

By:

   

/s/ Michael F. Sullivan

 

/s/ Lynda R. Keeton-Cardno

 

Michael F. Sullivan

Chief Executive Officer

(Principal Executive Officer)

 

Lynda R. Keeton-Cardno

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

18

21
0000945828 2017-12-31 0000945828 2017-06-30 0000945828 2017-10-01 2017-12-31 0000945828 2016-10-01 2016-12-31 0000945828 2017-07-01 2017-12-31 0000945828 2016-07-01 2016-12-31 0000945828 2016-06-30 0000945828 2016-12-31 0000945828 amty:WriteOffOfPreviouslyReservedForkliftTiresMember 2017-07-01 2017-12-31 0000945828 amty:WriteOffOfPreviouslyReservedForkliftTiresMember 2016-07-01 2016-12-31 0000945828 amty:WriteOffOfFullyDepreciatedFixedAssetsNoLongerInUseMember 2017-07-01 2017-12-31 0000945828 amty:WriteOffOfFullyDepreciatedFixedAssetsNoLongerInUseMember 2016-07-01 2016-12-31 0000945828 2018-02-14 0000945828 us-gaap:NotesPayableOtherPayablesMember 2017-07-01 2017-12-31 0000945828 us-gaap:NotesPayableOtherPayablesMember 2017-12-31 0000945828 us-gaap:NotesPayableOtherPayablesMember 2017-06-30 0000945828 2016-07-01 2016-07-31 0000945828 us-gaap:NotesPayableToBanksMember 2016-07-01 2016-07-31 0000945828 us-gaap:NotesPayableToBanksMember 2016-06-30 0000945828 us-gaap:NotesPayableToBanksMember 2016-06-01 2016-06-30 0000945828 us-gaap:NotesPayableToBanksMember 2016-07-31 0000945828 us-gaap:NotesPayableToBanksMember 2017-12-31 0000945828 2015-07-31 0000945828 us-gaap:ChiefExecutiveOfficerMember 2016-12-01 2016-12-01 0000945828 us-gaap:ChiefExecutiveOfficerMember 2016-12-01 0000945828 amty:OptionsGrantedJanuary19_2016Member us-gaap:ChiefFinancialOfficerMember 2017-07-01 2017-12-31 0000945828 2016-07-01 2017-06-30 0000945828 amty:OptionsAt0.08Member 2017-12-31 0000945828 amty:OptionsAt0.08Member 2017-07-01 2017-12-31 0000945828 amty:OptionsAt0.10Member 2017-12-31 0000945828 amty:OptionsAt0.10Member 2017-07-01 2017-12-31 0000945828 amty:OptionsAt017Member 2017-12-31 0000945828 amty:OptionsAt017Member 2017-07-01 2017-12-31 0000945828 us-gaap:ChiefFinancialOfficerMember us-gaap:SubsequentEventMember 2018-01-21 2018-01-21 iso4217:USD
iso4217:USD xbrli:shares xbrli:shares xbrli:pure